Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? - Yahoo Finance

Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs?  Yahoo Finance

MFN model for Medicaid revealed by CMS - pharmaphorum

MFN model for Medicaid revealed by CMS  pharmaphorum

Pharmaceutical Policy in Motion: Updates on the Trump Administration’s Drug Pricing Initiatives -...

Pharmaceutical Policy in Motion: Updates on the Trump Administration’s Drug Pricing Initiatives  The National Law Review

Dutch court upholds Venezuela award made using MFN clause - Global Arbitration Review

Dutch court upholds Venezuela award made using MFN clause  Global Arbitration Review

MFN scheme is less onerous than expected - BioCentury

MFN scheme is less onerous than expected  BioCentury

Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices - Pharma...

Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices  Pharmacy Times

The Long-Term Outlook for MFN Pricing: Far-Reaching Issues and Considerations - Pharmaceutical Ex...

The Long-Term Outlook for MFN Pricing: Far-Reaching Issues and Considerations  Pharmaceutical Executive

U.S. MFN Policy & China's Influence Continue to Stoke Fears Over ‘Korea Passing' - NAVLIN DAILY

U.S. MFN Policy & China's Influence Continue to Stoke Fears Over ‘Korea Passing'  NAVLIN DAILY

Many Unanswered Questions: Will the Trump Administration’s Drug Pricing Deals Result in Any Cost ...

Many Unanswered Questions: Will the Trump Administration’s Drug Pricing Deals Result in Any Cost Savings for State Medicaid Programs?  Georgetown University

Trump’s MFN price deals a wake-up call for governments in Europe - BioWorld MedTech

Trump’s MFN price deals a wake-up call for governments in Europe  BioWorld MedTech

AstraZeneca CEO visits White House to formalize MFN agreement with Trump - Fierce Pharma

AstraZeneca CEO visits White House to formalize MFN agreement with Trump  Fierce Pharma

Lilly, Novo to discount weight-loss drugs in MFN pricing deal with Trump - FirstWord Pharma

Lilly, Novo to discount weight-loss drugs in MFN pricing deal with Trump  FirstWord Pharma

Federal actions signal MFN drug pricing goal remains a priority - McDermott Will & Schulte

Federal actions signal MFN drug pricing goal remains a priority  McDermott Will & Schulte

Why MFN Pricing Hurts Patients and Innovation - U.S. Chamber of Commerce

Why MFN Pricing Hurts Patients and Innovation  U.S. Chamber of Commerce

Pharma R&D set to endure despite rising MFN costs - Pharmaceutical Technology

Pharma R&D set to endure despite rising MFN costs  Pharmaceutical Technology

Yellow To Get Ch. 11 Plan Ruling Next Week Amid MFN Row - Law360

Yellow To Get Ch. 11 Plan Ruling Next Week Amid MFN Row  Law360

MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market - Pharmacy Times

MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market  Pharmacy Times

Trump administration teases MFN drug pricing rule as commitment deadline looms for companies - Fi...

Trump administration teases MFN drug pricing rule as commitment deadline looms for companies  Fierce Pharma

AstraZeneca agrees to MFN pricing, joins TrumpRx - FirstWord Pharma

AstraZeneca agrees to MFN pricing, joins TrumpRx  FirstWord Pharma

J&J chief Joaquin Duato expects to find 'common ground' with Trump administration as industry's M...

J&J chief Joaquin Duato expects to find 'common ground' with Trump administration as industry's MFN talks play out  Fierce Pharma

CMS Announces Voluntary Medicaid MFN Pricing Model - NAVLIN DAILY

CMS Announces Voluntary Medicaid MFN Pricing Model  NAVLIN DAILY

MFN Executive Order Webinar: Inside Trump’s Drug Price Plan - Pharmaceutical Executive

MFN Executive Order Webinar: Inside Trump’s Drug Price Plan  Pharmaceutical Executive

CDMOs don’t expect immediate impact from ‘most favored nation’ deals - Endpoints News

CDMOs don’t expect immediate impact from ‘most favored nation’ deals  Endpoints News

Merck KGaA's EMD Serono strikes MFN deal in Trump's fertility treatment pricing push - Fierce Pharma

Merck KGaA's EMD Serono strikes MFN deal in Trump's fertility treatment pricing push  Fierce Pharma

Trump, Pfizer announce MFN deal; Lilly, others to come - pharmaphorum

Trump, Pfizer announce MFN deal; Lilly, others to come  pharmaphorum

Trump Attempts To Rein In Drug Prices With Most-Favored-Nation Approach - Skadden, Arps, Slate, M...

Trump Attempts To Rein In Drug Prices With Most-Favored-Nation Approach  Skadden, Arps, Slate, Meagher & Flom LLP

Pfizer shakes hands with White House on drug discounts under MFN programme - Pharmaceutical Techn...

Pfizer shakes hands with White House on drug discounts under MFN programme  Pharmaceutical Technology

"ForgeAlpha Academy Review – Worth paying attention to?.mfn" - Results on X | Live Posts & Update...

"ForgeAlpha Academy Review – Worth paying attention to?.mfn" - Results on X | Live Posts & Updates  x.com

Trump Administration ‘Deep into MFN Negotiations’ with 14 Companies - NAVLIN DAILY

Trump Administration ‘Deep into MFN Negotiations’ with 14 Companies  NAVLIN DAILY

Novo Nordisk and Eli Lilly Strike MFN Deal with White House Over Anti-Obesity Drugs - NAVLIN DAILY

Novo Nordisk and Eli Lilly Strike MFN Deal with White House Over Anti-Obesity Drugs  NAVLIN DAILY

Trump revives plan for IRP use in US via MFN executive order - Pharmaceutical Technology

Trump revives plan for IRP use in US via MFN executive order  Pharmaceutical Technology

The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S. - Pharmaceutical Executive

The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.  Pharmaceutical Executive

UPDATED: Pfizer offers price concessions, $70B US outlay in Trump's 'most favored nation' push - ...

UPDATED: Pfizer offers price concessions, $70B US outlay in Trump's 'most favored nation' push  Fierce Pharma

U.S. launches pilot payment model to bring MFN pricing to Medicaid - Seeking Alpha

U.S. launches pilot payment model to bring MFN pricing to Medicaid  Seeking Alpha

Pfizer inks first MFN drug pricing deal as US introduces 'TrumpRx' DTC site - FirstWord Pharma

Pfizer inks first MFN drug pricing deal as US introduces 'TrumpRx' DTC site  FirstWord Pharma

The MFN Executive Order: A Global Reset for U.S. Pharma - MedCity News

The MFN Executive Order: A Global Reset for U.S. Pharma  MedCity News

Mintz IRA Update — Under Pressure: The Trump Administration’s Drug Pricing Executive Orders - Mintz

Mintz IRA Update — Under Pressure: The Trump Administration’s Drug Pricing Executive Orders  Mintz

Lilly Statement: MFN Pricing Targeted for September 1, Pushback on Pharma Tariffs - BioPharm Inte...

Lilly Statement: MFN Pricing Targeted for September 1, Pushback on Pharma Tariffs  BioPharm International

Pfizer CEO touts 'extremely productive' talks with Trump administration as MFN pricing, tariff th...

Pfizer CEO touts 'extremely productive' talks with Trump administration as MFN pricing, tariff threats close in  Fierce Pharma

‘Most-favored nation’ pricing is dangerous to drug innovation - The Wilson Times

‘Most-favored nation’ pricing is dangerous to drug innovation  The Wilson Times

The Top Questions for the President’s MFN Order - Pharmaceutical Executive

The Top Questions for the President’s MFN Order  Pharmaceutical Executive

AstraZeneca CEO: 'We can absorb the impact' of drug pricing deal with Trump - Fierce Pharma

AstraZeneca CEO: 'We can absorb the impact' of drug pricing deal with Trump  Fierce Pharma

The Global Risks of America’s “Most-Favored-Nation” Drug Pricing Policy - Petrie-Flom Center

The Global Risks of America’s “Most-Favored-Nation” Drug Pricing Policy  Petrie-Flom Center

Novo, Lilly sign MFN pricing deal with Trump administration - pharmaphorum

Novo, Lilly sign MFN pricing deal with Trump administration  pharmaphorum

Pharma Industry Execs React to President Trump’s 60-Day MFN Deadline - Pharmaceutical Executive

Pharma Industry Execs React to President Trump’s 60-Day MFN Deadline  Pharmaceutical Executive

Amid MFN talks, Lilly chief warns US adoption of international drug prices could bring 'worst of ...

Amid MFN talks, Lilly chief warns US adoption of international drug prices could bring 'worst of two worlds'  Fierce Pharma

Watch Tuesday: MFN, tariffs and a DTC push — Inside Trump’s drug-pricing reset - Medical Economics

Watch Tuesday: MFN, tariffs and a DTC push — Inside Trump’s drug-pricing reset  Medical Economics

What the Most Favored Nation Executive Order Means to Pharma Brands and Future Implications - Pha...

What the Most Favored Nation Executive Order Means to Pharma Brands and Future Implications  Pharmaceutical Executive

Is Trump’s MFN pricing order more bark than bite? - Fierce Pharma

Is Trump’s MFN pricing order more bark than bite?  Fierce Pharma

Trump administration announces MFN drug pricing deal with Pfizer - Yahoo Finance

Trump administration announces MFN drug pricing deal with Pfizer  Yahoo Finance

Tariffs and MFN Policy Power a Broad, Confusing Pharma War - BioSpace

Tariffs and MFN Policy Power a Broad, Confusing Pharma War  BioSpace

Merck joins the Trump MFN gang with IVF deal - pharmaphorum

Merck joins the Trump MFN gang with IVF deal  pharmaphorum

Drug Channels News Roundup, May 2025: MFN Controversy, Plan Sponsors ♥️ Rebates, PBM Profits, and...

Drug Channels News Roundup, May 2025: MFN Controversy, Plan Sponsors ♥️ Rebates, PBM Profits, and Fun in Congress  Drug Channels

Trump announces drug pricing deal with AstraZeneca - The Hill

Trump announces drug pricing deal with AstraZeneca  The Hill

White House raises more questions than answers in Executive Order directing Most Favored Nation d...

White House raises more questions than answers in Executive Order directing Most Favored Nation drug pricing  www.hoganlovells.com

LAST WEEK IN REVIEW - NAVLIN DAILY

LAST WEEK IN REVIEW  NAVLIN DAILY

Four Companies Feeling Effect of MFN in Japan, EFPIA Japan Survey Finds - NAVLIN DAILY

Four Companies Feeling Effect of MFN in Japan, EFPIA Japan Survey Finds  NAVLIN DAILY

The New Antitrust Frontier: How the “Most-Favored Nation” (MFN) Executive Order Targets Drug Pric...

The New Antitrust Frontier: How the “Most-Favored Nation” (MFN) Executive Order Targets Drug Pricing Power  Winston & Strawn

Pfizer Reaches First Agreement with White House on MFN Pricing; Who Will Be Next? - PharmTech.com

Pfizer Reaches First Agreement with White House on MFN Pricing; Who Will Be Next?  PharmTech.com

Lilly, Novo Nordisk Among Latest Pharma Giants To Commit To Trump's MFN Drug Pricing Policy - Nasdaq

Lilly, Novo Nordisk Among Latest Pharma Giants To Commit To Trump's MFN Drug Pricing Policy  Nasdaq

AstraZeneca joins Pfizer in MFN pricing deal with US - pharmaphorum

AstraZeneca joins Pfizer in MFN pricing deal with US  pharmaphorum

The Trump Administration Continues Focus on Drug Pricing with “Most-Favored-Nation Prescription D...

The Trump Administration Continues Focus on Drug Pricing with “Most-Favored-Nation Prescription Drug Pricing” Executive Order  akingump.com

Post-Hoc Live: M&A, FDA, MFN and more — with our cousins at the FT - Endpoints News

Post-Hoc Live: M&A, FDA, MFN and more — with our cousins at the FT  Endpoints News

What Could the Global Impact of the MFN Order Be? - Pharmaceutical Executive

What Could the Global Impact of the MFN Order Be?  Pharmaceutical Executive

White House unveils MFN deals; Metsera saga ends; Q3 earnings updates; and more - Endpoints News

White House unveils MFN deals; Metsera saga ends; Q3 earnings updates; and more  Endpoints News

White House announces steps for drug manufacturers to meet ‘most favored nation’ pricing - Americ...

White House announces steps for drug manufacturers to meet ‘most favored nation’ pricing  American Hospital Association

How Most-Favored Nation Policy Could Undermine U.S. Leadership - CSIS | Center for Strategic and ...

How Most-Favored Nation Policy Could Undermine U.S. Leadership  CSIS | Center for Strategic and International Studies

Policy in Focus: Trump’s MFN deals, FDA vouchers, and the government shutdown - pharmaphorum

Policy in Focus: Trump’s MFN deals, FDA vouchers, and the government shutdown  pharmaphorum

Industry hopes concessions short of MFN will satisfy Trump, BIO chair says - BioCentury

Industry hopes concessions short of MFN will satisfy Trump, BIO chair says  BioCentury

Inside the MFN Pricing Actions - Pharmaceutical Commerce

Inside the MFN Pricing Actions  Pharmaceutical Commerce

Trump Sends Letters to 17 Leading Pharma Companies Outlining Most-Favored-Nation Drug Pricing Pro...

Trump Sends Letters to 17 Leading Pharma Companies Outlining Most-Favored-Nation Drug Pricing Protocol  PharmTech.com

AstraZeneca agrees to MFN price reductions with US government - European Biotechnology Magazine

AstraZeneca agrees to MFN price reductions with US government  European Biotechnology Magazine

Executive Order to Lower U.S. Drug Prices Could Hurt the Poorest Countries - Think Global Health

Executive Order to Lower U.S. Drug Prices Could Hurt the Poorest Countries  Think Global Health

Industry races to counter Trump MFN threat - BioCentury

Industry races to counter Trump MFN threat  BioCentury

NATO for medicines? Pfizer CEO calls for higher drug spending outside US amid Trump’s MFN pricing...

NATO for medicines? Pfizer CEO calls for higher drug spending outside US amid Trump’s MFN pricing push  Fierce Pharma

Lilly, Novo MFN deals expected to ‘democratize’ obesity drugs - BioWorld MedTech

Lilly, Novo MFN deals expected to ‘democratize’ obesity drugs  BioWorld MedTech

Eli Lilly, Novo Nordisk strike deals with White House to cut prices of weight loss drugs - Fierce...

Eli Lilly, Novo Nordisk strike deals with White House to cut prices of weight loss drugs  Fierce Pharma

Trump Administration Strikes Third MFN Deal with EMD Serono, Announces National Priority Voucher ...

Trump Administration Strikes Third MFN Deal with EMD Serono, Announces National Priority Voucher Recipients  NAVLIN DAILY

Pfizer MFN deal changes nothing and everything - BioCentury

Pfizer MFN deal changes nothing and everything  BioCentury

MFN And Confidential Pricing: What Experts Said - Citeline News & Insights

MFN And Confidential Pricing: What Experts Said  Citeline News & Insights

Trump’s MFN Drug Pricing Push Targets 17 Big Pharma Companies, Spurs Global Industry Response - P...

Trump’s MFN Drug Pricing Push Targets 17 Big Pharma Companies, Spurs Global Industry Response  Pharmaceutical Commerce

MFN pricing is dangerous to drug innovation - AFRO American Newspapers

MFN pricing is dangerous to drug innovation  AFRO American Newspapers

In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy ...

In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy  Fierce Pharma

Opinion: Understanding What Trump’s MFN Executive Order Can and Can’t Do - BioSpace

Opinion: Understanding What Trump’s MFN Executive Order Can and Can’t Do  BioSpace

AstraZeneca Is Next to Reach MFN Deal with White House - PharmTech.com

AstraZeneca Is Next to Reach MFN Deal with White House  PharmTech.com

President Trump Issues Letters to 17 Major Pharma Companies Demanding Action on Most-Favored-Nati...

President Trump Issues Letters to 17 Major Pharma Companies Demanding Action on Most-Favored-Nation Order  Pharmaceutical Executive

Pharmaceutical Industry Faces Legal Uncertainty Over MFN Executive Order - Pharmaceutical Executive

Pharmaceutical Industry Faces Legal Uncertainty Over MFN Executive Order  Pharmaceutical Executive

Pfizer Agrees to Lower Certain Drug Prices in US, Aligning With Most-Favored Nation Plan - Pharma...

Pfizer Agrees to Lower Certain Drug Prices in US, Aligning With Most-Favored Nation Plan  Pharmacy Times

Pharma Must Unite On MFN Launch Prices To Boost Rates Abroad, CMS’ Brooks Says - Citeline News & ...

Pharma Must Unite On MFN Launch Prices To Boost Rates Abroad, CMS’ Brooks Says  Citeline News & Insights

6 Things You Need to Know About MFN Drug Pricing | MJH Life Sciences Webinar - Managed Healthcare...

6 Things You Need to Know About MFN Drug Pricing | MJH Life Sciences Webinar  Managed Healthcare Executive

Pfizer’s MFN deal, new trial paradigm & TCG X’s $1.3B fund — a BioCentury podcast - BioCentury

Pfizer’s MFN deal, new trial paradigm & TCG X’s $1.3B fund — a BioCentury podcast  BioCentury

Administration Revisits Idea of MFN Pricing, but Logistics Are Unclear - AIS Health

Administration Revisits Idea of MFN Pricing, but Logistics Are Unclear  AIS Health

US misuse of tariff reciprocity and what the world should do about it - CEPR

US misuse of tariff reciprocity and what the world should do about it  CEPR

White House threatens to 'deploy every tool in our arsenal' to implement most-favored-nation drug...

White House threatens to 'deploy every tool in our arsenal' to implement most-favored-nation drug pricing  Fierce Pharma

A Warning on China’s Most Favored Nation Status - China-US Focus

A Warning on China’s Most Favored Nation Status  China-US Focus

President Trump Announces MFN Drug Pricing Deal with Pfizer - NAVLIN DAILY

President Trump Announces MFN Drug Pricing Deal with Pfizer  NAVLIN DAILY

White House Strikes GLP-1 Pricing Deal With Lilly, Novo - BioSpace

White House Strikes GLP-1 Pricing Deal With Lilly, Novo  BioSpace

A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform...

A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform  The American Journal of Managed Care® (AJMC®)

What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients - Pharmaceutical Ex...

What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients  Pharmaceutical Executive

With second deal, MFN comes into focus - BioCentury

With second deal, MFN comes into focus  BioCentury